CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance (in shares) at Jun. 30, 2023			2,277,828
Balance at Jun. 30, 2023		$ (36,730)	$ 114	$ 66,764	$ 9,023	$ (112,631)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(141)				(141)
Foreign currency translation		(227)			(227)
Stock-based compensation		1,292		1,292
Net restricted stock activity (in shares)			2,120
Net restricted stock activity		(16)		(16)
Stock issued in connection with Alline Acquisition		0
Balance (in shares) at Mar. 31, 2024			2,279,948
Balance at Mar. 31, 2024		(35,822)	$ 114	68,040	8,796	(112,772)
Balance (in shares) at Dec. 31, 2023			2,279,450
Balance at Dec. 31, 2023		(33,590)	$ 114	67,710	9,026	(110,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(2,332)				(2,332)
Foreign currency translation		(230)			(230)
Stock-based compensation		333		333
Net restricted stock activity (in shares)			498
Net restricted stock activity		(3)		(3)
Balance (in shares) at Mar. 31, 2024			2,279,948
Balance at Mar. 31, 2024		$ (35,822)	$ 114	68,040	8,796	(112,772)
Balance (in shares) at Jun. 30, 2024		2,279,948	2,279,948
Balance at Jun. 30, 2024		$ 56,787	$ 114	69,660	8,584	(21,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		7,042				7,042
Foreign currency translation		(411)			(411)
Stock-based compensation		1,048		1,048
Net restricted stock activity (in shares)			15,481
Net restricted stock activity		(74)	$ 1	(75)
Common stock issued in connection with Alline Acquisition (in shares)	[1]		140,552
Stock issued in connection with Alline Acquisition	[1]	3,000	$ 7	2,993
Stock warrants issued in connection with debt		$ 1,252		1,252
Balance (in shares) at Mar. 31, 2025		2,435,981	2,435,981
Balance at Mar. 31, 2025		$ 68,644	$ 122	74,878	8,173	(14,529)
Balance (in shares) at Dec. 31, 2024			2,435,981
Balance at Dec. 31, 2024		66,718	$ 122	73,243	8,132	(14,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		250				250
Foreign currency translation		41			41
Stock-based compensation		383		383
Stock warrants issued in connection with debt		$ 1,252		1,252
Balance (in shares) at Mar. 31, 2025		2,435,981	2,435,981
Balance at Mar. 31, 2025		$ 68,644	$ 122	$ 74,878	$ 8,173	$ (14,529)

[1] This activity represents the common stock issued in connection with the Alline Acquisition on December 19, 2024. See Note 13 for additional details.